ROLE OF DIFFUSION WEIGHTED IMAGING AND DYNAMIC CONTRAST ENHANCED MAGNETIC RESONANCE IMAGING IN CHARACTERIZING BENIGN AND MALIGNANT BREAST LESIONS
Main Article Content
Keywords
Breast cancer, Diffusion-weighted imaging, Dynamic contrast-enhanced MRI, Apparentdiffusion coefficient, Multiparametric MRI, Lesion characterization
Abstract
Background: Accurate differentiation between benign and malignant breast lesions is crucial for early diagnosis and optimal management. Multiparametric MRI, combining diffusion-weighted imaging (DWI) and dynamic contrast-enhanced MRI (DCE-MRI), offers both anatomical and functional assessment, potentially improving diagnostic accuracy.
Objective: To evaluate the role of DWI and DCE-MRI in characterizing benign and malignant breast lesions and to determine optimal ADC cut-off values for lesion differentiation.
Materials and Methods: This prospective, observational study included 100 female patients with breast lesions. All participants underwent mammography, ultrasound, and 3.0T MRI with DWI (b = 400, 800 s/mm²) and DCE sequences. Lesions were evaluated for morphology, size, margins, signal intensity, diffusion restriction, and contrast enhancement. ADC values were calculated, and MRI findings were correlated with histopathology or FNAC results. Statistical analysis included sensitivity, specificity, predictive values, accuracy, and ROC curve analysis for ADC thresholds.
Results: Malignant lesions demonstrated significantly lower ADC values compared to benign lesions (mean ADC: 0.93 ×10⁻³ mm²/s vs. 1.45 ×10⁻³ mm²/s, p < 0.001). DWI alone achieved 88.5% sensitivity and 81.3% specificity, while DCE-MRI showed 92.3% sensitivity and 79.2% specificity. Combined DWI and DCE-MRI improved sensitivity to 96.2%, specificity to 87.5%, and overall accuracy to 92.0%. ROC analysis identified a mean ADC cut-off ≤1.00 ×10⁻³ mm²/s with 92.3% sensitivity and 87.5% specificity. Higher BI-RADS categories and morphological features such as irregular shape and spiculated margins were strongly associated with malignancy.
Conclusion: Multiparametric MRI integrating DWI and DCE-MRI provides excellent diagnostic performance for differentiating benign and malignant breast lesions. ADC quantification enhances specificity, and combined imaging improves overall accuracy, supporting its use in routine clinical practice to optimize early detection and management of breast cancer.
References
2. Berg WA, Gutierrez L, NessAiver MS, Carter WB, Bhargavan M, Lewis RS, et al. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology. 2004;233(3):830 49.
3. Kuhl CK. Current status of breast MR imaging. Part 2. Clinical applications. Radiology. 2007;244(3):672 91.
4. Le Bihan D, Breton E, Lallemand D, Aubin ML, Vignaud J, Laval Jeantet M, et al. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology. 1988;168(2):497 505.
5. Woodhams R, Ramadan S, Stanwell P, Sakamoto S, Hata H, Ozaki M, et al. Diffusion weighted imaging of the breast: principles and clinical applications. Radiographics. 2011;31(4):1059 84.
6. Guo Y, Cai YQ, Cai ZL, Gong ZY, An NY, Chen ZH, et al. Differentiation of clinically benign and malignant breast lesions using diffusion weighted imaging. J Magn Reson Imaging. 2002;16(2):172 8.
7. Woodhams R, Matsunaga K, Kan S, Imai H, Kojima Y, Hamada A, et al. ADC mapping of benign and malignant breast tumors. Magn Reson Med Sci. 2005;4(1):35 42.
8. Partridge SC, DeMartini WB, Kurland BF, Eby PR, White SW, Lehman CD, et al. Differential diagnosis of mammographically and clinically occult breast lesions on diffusion weighted MRI. J Magn Reson Imaging. 2010;31(3):562 70.
9. Rahbar H, Partridge SC, Eby PR, DeMartini WB, Gutierrez RL, Peacock S, et al. Characterization of ductal carcinoma in situ on diffusion weighted breast MRI. Eur Radiol. 2011;21(9):2011 9.
10. Kul S, Cansu A, Alhan E, Dinc H, Gunes G, Reis A, et al. Contribution of diffusion weighted imaging to dynamic contrast enhanced MRI in the characterization of breast tumors. AJR Am J Roentgenol. 2011;196(1):210 7.
11. Ahluwalia KS, Narula H, Jain A, Arora A, Vohra A, Bansal T, et al. Role of MRI in differentiating benign from malignant breast lesions using dynamic contrast enhanced MRI and diffusion weighted MRI. J Evol Med Dent Sci. 2021;10(19):1422 9.
12. Surov A, Meyer HJ, Wienke A. Can apparent diffusion coefficient (ADC) distinguish breast cancer from benign breast findings? A meta analysis based on 13 847 lesions. BMC Cancer. 2019;19:955.
13. Cai H, Liu L, Peng Y, Wu Y, Li L. Diagnostic assessment by dynamic contrast enhanced and diffusion weighted magnetic resonance in differentiation of breast lesions under different imaging protocols. BMC Cancer. 2014;14:366.
14. Partridge SC, Rahbar H, Murthy R, Chai X, Kurland BF, DeMartini WB, et al. Improved diagnostic accuracy of breast MRI through combined apparent diffusion coefficients and dynamic contrast enhanced kinetics. Magn Reson Med. 2011;65(6):1759 67.
15. Pinker K, Bickel H, Helbich TH, Gruber S, Dubsky P, Pluschnig U, et al. Combined contrast enhanced magnetic resonance and diffusion weighted imaging reading adapted to the “Breast Imaging Reporting and Data System” for multiparametric 3 T imaging of breast lesions. Eur Radiol. 2013;23(7):1791 802.
16. Tezcan S, Ozturk FU, Uslu N, Akcay EY. The role of combined diffusion weighted imaging and dynamic contrast enhanced MRI for differentiating malignant from benign breast lesions presenting washout curve. Can Assoc Radiol J. 2021;72(3):460 69.

